Importantly, heterozygous genomic deletions of several metabolic enzymes that are essential for neoplastic transformation have been found not to result in developmental or growth abnormalities [45-48], and we postulate that certain metabolic enzymes such as AAT may prove to be the Achilles' heel of breast cancer cells. Here, SERPINA1 is linked to breast carcinoma.